Genesis Molecular AI Appoints Sergey Edunov as Senior Vice President of Foundation Models, Further Strengthening Leadership in Machine Learning
Genesis Molecular AI, the company pioneering the world’s leading AI models for drug design and development, today announced the appointment of Sergey Edunov as Senior Vice President of Foundation Models.
Genesis Molecular AI Unveils Pearl, a Field-Leading Foundation Model that Achieves Unprecedented Performance in Drug-Protein Structure Prediction
Genesis Molecular AI, the company pioneering the world’s leading molecular AI models for drug design and development, today announced Pearl, a generative foundation model for biomolecular structure prediction trained with novel architecture, training methodology, and large-scale synthetic data. Genesis released a new study, co-authored with subject matter experts from NVIDIA, demonstrating that Pearl outperforms existing models, including AlphaFold 3, in successfully predicting how small molecules bind to proteins.
